共有 50 笔近期内部人交易记录记录，涉及 Emmaus Life Sciences, Inc. (EMMA), 包括 46 笔买入 和 3 笔卖出. 内部人买入总额为 $44.65M 内部人卖出总额为 $1.07M.
近期活跃的重要内部人包括 Kuwahara Jon, Lim Seah H., Lee Willis C. 内部人交易记录可以揭示公司管理层对股票估值和未来前景的看法.
内部人交易记录 — EMMA
| 日期 |
姓名 |
职位 |
交易类型 |
股数 |
平均价格 |
总价值 |
持股数量 |
| 2024-10-01 |
Kuwahara Jon |
Officer |
未知 |
- |
- |
- |
- |
| 2024-09-16 |
Lim Seah H. |
Director |
知情买入 |
20,000 |
$0.04 |
$800.00 |
4,606,626 |
| 2024-02-29 |
Lee Willis C |
Co-president & COO |
知情买入 |
77,000 |
$0.13 |
$10.01K |
159,400 |
| 2024-02-28 |
Lee Willis C |
Co-president & COO |
知情买入 |
15,000 |
$0.12 |
$1.8K |
82,400 |
| 2024-02-27 |
Lee Willis C |
Co-president & COO |
知情买入 |
10,000 |
$0.13 |
$1.3K |
67,400 |
| 2024-02-26 |
Lee Willis C |
Co-president & COO |
知情买入 |
13,200 |
$0.12 |
$1.58K |
57,400 |
| 2024-02-01 |
Lee Willis C |
Co-president & COO |
限制性股票授予 (RSU) |
200,000 |
$0.15 |
$30K |
200,000 |
| 2024-02-01 |
Nagasaki Yasushi |
CFO |
限制性股票授予 (RSU) |
200,000 |
$0.15 |
$30K |
200,000 |
| 2024-02-01 |
Zwicker Ian Harvey |
Director |
限制性股票授予 (RSU) |
100,000 |
$0.15 |
$15K |
100,000 |
| 2024-02-01 |
Zen Wei Peu |
Director |
限制性股票授予 (RSU) |
100,000 |
$0.15 |
$15K |
100,000 |
| 2024-02-01 |
Sekulich George |
Co-president & Cco |
限制性股票授予 (RSU) |
200,000 |
$0.15 |
$30K |
200,000 |
| 2024-02-01 |
Stark Charles William |
CSO & EVP Clinical Development |
限制性股票授予 (RSU) |
200,000 |
$0.15 |
$30K |
200,000 |
| 2024-02-01 |
Lim Seah H. |
Director |
限制性股票授予 (RSU) |
100,000 |
$0.15 |
$15K |
100,000 |
| 2023-12-20 |
Lim Seah H. |
Director |
知情卖出 |
32,500 |
$0.05 |
$1.63K |
4,586,626 |
| 2023-12-15 |
Zen Wei Peu |
Director |
其他（买入） |
3,760,983 |
$0.29 |
$1.09M |
4,768,817 |
| 2023-12-15 |
Lim Seah H. |
Director |
其他（卖出） |
240,000 |
$0.29 |
$69.6K |
- |
| 2023-11-30 |
Lee Willis C |
COO |
知情买入 |
59,400 |
$0.12 |
$7.13K |
395,124 |
| 2023-11-30 |
Lee Willis C |
COO |
知情买入 |
7,417 |
$0.12 |
$890.04 |
395,124 |
| 2023-11-29 |
Lee Willis C |
COO |
知情买入 |
36,000 |
$0.12 |
$4.32K |
335,724 |
| 2023-11-29 |
Lee Willis C |
COO |
知情买入 |
4,325 |
$0.12 |
$519.00 |
335,724 |
| 2023-11-28 |
Lee Willis C |
COO |
知情买入 |
12,000 |
$0.12 |
$1.44K |
299,724 |
| 2023-11-28 |
Lee Willis C |
COO |
知情买入 |
1,470 |
$0.12 |
$176.40 |
299,724 |
| 2023-11-14 |
Lee Willis C |
COO |
知情买入 |
1,100 |
$0.12 |
$132.00 |
44,200 |
| 2023-11-14 |
Lee Willis C |
COO |
知情买入 |
132 |
$0.12 |
$15.84 |
44,200 |
| 2023-09-05 |
Lim Seah H. |
Director |
知情买入 |
1,700 |
$0.15 |
$255.00 |
177,700 |
| 2023-08-31 |
Lee Willis C |
COO |
知情买入 |
6,000 |
$0.15 |
$900.00 |
43,100 |
| 2023-08-31 |
Lee Willis C |
COO |
知情买入 |
900 |
$0.15 |
$135.00 |
43,100 |
| 2023-08-30 |
Lim Seah H. |
Director |
知情买入 |
20,000 |
$0.15 |
$3K |
176,000 |
| 2023-08-25 |
Lee Willis C |
COO |
知情买入 |
6,500 |
$0.21 |
$1.37K |
37,100 |
| 2023-08-25 |
Lee Willis C |
COO |
知情买入 |
1,365 |
$0.21 |
$286.65 |
37,100 |
| 2023-08-25 |
Lim Seah H. |
Director |
知情买入 |
92,100 |
$0.27 |
$24.87K |
156,000 |
| 2023-05-31 |
Lee Willis C |
COO |
知情买入 |
28,700 |
$0.29 |
$8.32K |
30,600 |
| 2023-01-18 |
Zen Wei Peu |
Director |
知情买入 |
2,000,000 |
$0.50 |
$1M |
2,000,000 |
| 2023-01-18 |
Zen Wei Peu |
Director |
其他（卖出） |
2,000,000 |
$0.50 |
$1M |
- |
| 2023-01-12 |
Niihara Yutaka |
Chairman and CEO |
限制性股票授予 (RSU) |
7,500,000 |
$4.50 |
$33.75M |
- |
| 2023-01-12 |
Lee Willis C |
COO |
限制性股票授予 (RSU) |
750,000 |
$4.50 |
$3.38M |
750,000 |
| 2023-01-12 |
Nagasaki Yasushi |
CFO |
限制性股票授予 (RSU) |
150,000 |
$4.50 |
$675K |
150,000 |
| 2023-01-12 |
Zwicker Ian Harvey |
Director |
限制性股票授予 (RSU) |
100,000 |
$4.50 |
$450K |
100,000 |
| 2023-01-12 |
Zen Wei Peu |
Director |
限制性股票授予 (RSU) |
100,000 |
$4.50 |
$450K |
100,000 |
| 2023-01-12 |
Sekulich George |
CIO & SVP |
限制性股票授予 (RSU) |
100,000 |
$4.50 |
$450K |
100,000 |
| 2023-01-12 |
Stark Charles William |
SVP, Clinical Development |
限制性股票授予 (RSU) |
100,000 |
$4.50 |
$450K |
100,000 |
| 2023-01-12 |
Lim Seah H. |
Director |
限制性股票授予 (RSU) |
100,000 |
$4.50 |
$450K |
100,000 |
| 2023-01-12 |
Lee Willis C |
COO |
限制性股票授予 (RSU) |
500,000 |
$4.50 |
$2.25M |
500,000 |
| 2022-11-30 |
Niihara Yutaka |
Chairman and CEO |
知情买入 |
22,900 |
$0.41 |
$9.39K |
12,040,857 |
| 2022-11-29 |
Niihara Yutaka |
Chairman and CEO |
知情买入 |
14,700 |
$0.38 |
$5.59K |
12,017,957 |
| 2022-11-28 |
Niihara Yutaka |
Chairman and CEO |
知情买入 |
5,000 |
$0.35 |
$1.75K |
12,003,257 |
| 2022-11-04 |
Niihara Yutaka |
Chairman and CEO |
知情买入 |
7,500 |
$0.45 |
$3.38K |
11,998,257 |
| 2022-11-03 |
Niihara Yutaka |
Chairman and CEO |
知情买入 |
2,500 |
$0.45 |
$1.13K |
11,990,757 |
| 2022-11-02 |
Niihara Yutaka |
Chairman and CEO |
知情买入 |
15,000 |
$0.43 |
$6.45K |
11,988,257 |
| 2022-11-01 |
Niihara Yutaka |
Chairman and CEO |
知情买入 |
5,000 |
$0.43 |
$2.15K |
11,973,257 |
■ 知情交易 — 公开市场买卖（最具参考价值）
■ 非知情买入 — 奖励、期权行权、转换
■ 非知情卖出 — 税务代扣、归属出售
■ 中性 — 礼赠、信托、到期
